EuTCV

BIOLOGICAL2 trials

Sponsors

EuBiologics Co.,Ltd, EuBiologics Co. Ltd.

Conditions

Typhoid FeverTyphoid fever

Phase 1

Safety and Tolerability of Typhoid Conjugate Vaccine (EuTCV) in Healthy Adults

CompletedNCT03956524

EuBiologics Co.,LtdTyphoid Fever

Start: 2019-03-16End: 2019-08-31Updated: 2019-12-09

Unknown Phase

CVIA 113 - Observational study to evaluate long-term immune persistance of EuTCV vaccine administered in Senagalese children on CVIA092 study

Active, not recruitingPACTR202605522385822

EuBiologics Co. Ltd.Typhoid fever

Start: 2026-03-01Target: 465Updated: 2026-08-03

Related Papers

An open-label, comparative, single dose, clinical Phase Ⅰ study to assess the safety and immunogenicity of typhoid conjugate vaccine (Vi-CRM197) in healthy Filipino adults.

2021-04-107 citations